124 related articles for article (PubMed ID: 12968069)
1. Lycopene increases urokinase receptor and fails to inhibit growth or connexin expression in a metastatically passaged prostate cancer cell line: a brief communication.
Forbes K; Gillette K; Sehgal I
Exp Biol Med (Maywood); 2003 Sep; 228(8):967-71. PubMed ID: 12968069
[TBL] [Abstract][Full Text] [Related]
2. Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumor cells.
Livny O; Kaplan I; Reifen R; Polak-Charcon S; Madar Z; Schwartz B
J Nutr; 2002 Dec; 132(12):3754-9. PubMed ID: 12468619
[TBL] [Abstract][Full Text] [Related]
3. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines.
Ivanov NI; Cowell SP; Brown P; Rennie PS; Guns ES; Cox ME
Clin Nutr; 2007 Apr; 26(2):252-63. PubMed ID: 17337101
[TBL] [Abstract][Full Text] [Related]
4. Lycopene acts through inhibition of IκB kinase to suppress NF-κB signaling in human prostate and breast cancer cells.
Assar EA; Vidalle MC; Chopra M; Hafizi S
Tumour Biol; 2016 Jul; 37(7):9375-85. PubMed ID: 26779636
[TBL] [Abstract][Full Text] [Related]
5. Oral cancer cells differ from normal oral epithelial cells in tissue like organization and in response to lycopene treatment: an organotypic cell culture study.
Livny O; Kaplan I; Reifen R; Polak-Charcon S; Madar Z; Schwartz B
Nutr Cancer; 2003; 47(2):195-209. PubMed ID: 15087273
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of RARalpha, RARbeta, and Cx43 in breast tumor cell lines after treatment with lycopene and correlation with RT-QPCR.
Chalabi N; Delort L; Satih S; Déchelotte P; Bignon YJ; Bernard-Gallon DJ
J Histochem Cytochem; 2007 Sep; 55(9):877-83. PubMed ID: 17438348
[TBL] [Abstract][Full Text] [Related]
7. Lycopene's Effects on Cancer Cell Functions within Monolayer and Spheroid Cultures.
Holzapfel NP; Holzapfel BM; Theodoropoulos C; Kaemmerer E; Rausch T; Feldthusen J; Champ S; Clements JA; Hutmacher DW; Loessner D
Nutr Cancer; 2016; 68(2):350-63. PubMed ID: 27015041
[TBL] [Abstract][Full Text] [Related]
8. The influence of lycopene on the proliferation of human breast cell line (MCF-7).
Fornelli F; Leone A; Verdesca I; Minervini F; Zacheo G
Toxicol In Vitro; 2007 Mar; 21(2):217-23. PubMed ID: 17140762
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of urokinase plasminogen activator receptor in prostate cancer cells derived from repeated metastasis.
Forbes K; Gillette K; Kelley LA; Sehgal I
World J Urol; 2004 Apr; 22(1):67-71. PubMed ID: 15052500
[TBL] [Abstract][Full Text] [Related]
10. Effect of lycopene on prostate LNCaP cancer cells in culture.
Kim L; Rao AV; Rao LG
J Med Food; 2002; 5(4):181-7. PubMed ID: 12639392
[TBL] [Abstract][Full Text] [Related]
11. Lycopene effects contributing to prostate health.
Wertz K
Nutr Cancer; 2009; 61(6):775-83. PubMed ID: 20155615
[TBL] [Abstract][Full Text] [Related]
12. Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1.
Nahum A; Zeller L; Danilenko M; Prall OW; Watts CK; Sutherland RL; Levy J; Sharoni Y
Eur J Nutr; 2006 Aug; 45(5):275-82. PubMed ID: 16565789
[TBL] [Abstract][Full Text] [Related]
13. Overview of mechanisms of action of lycopene.
Heber D; Lu QY
Exp Biol Med (Maywood); 2002 Nov; 227(10):920-3. PubMed ID: 12424335
[TBL] [Abstract][Full Text] [Related]
14. Lycopene: modes of action to promote prostate health.
Wertz K; Siler U; Goralczyk R
Arch Biochem Biophys; 2004 Oct; 430(1):127-34. PubMed ID: 15325920
[TBL] [Abstract][Full Text] [Related]
15. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells.
Karas M; Amir H; Fishman D; Danilenko M; Segal S; Nahum A; Koifmann A; Giat Y; Levy J; Sharoni Y
Nutr Cancer; 2000; 36(1):101-11. PubMed ID: 10798222
[TBL] [Abstract][Full Text] [Related]
16. Lycopene.
Cassileth B
Oncology (Williston Park); 2010 Mar; 24(3):296. PubMed ID: 20394143
[TBL] [Abstract][Full Text] [Related]
17. Combined lycopene and vitamin E treatment suppresses the growth of PC-346C human prostate cancer cells in nude mice.
Limpens J; Schröder FH; de Ridder CM; Bolder CA; Wildhagen MF; Obermüller-Jevic UC; Krämer K; van Weerden WM
J Nutr; 2006 May; 136(5):1287-93. PubMed ID: 16614418
[TBL] [Abstract][Full Text] [Related]
18. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene.
Levy J; Bosin E; Feldman B; Giat Y; Miinster A; Danilenko M; Sharoni Y
Nutr Cancer; 1995; 24(3):257-66. PubMed ID: 8610045
[TBL] [Abstract][Full Text] [Related]
19. Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells.
Hantz HL; Young LF; Martin KR
Exp Biol Med (Maywood); 2005 Mar; 230(3):171-9. PubMed ID: 15734720
[TBL] [Abstract][Full Text] [Related]
20. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
Kucuk O; Sarkar FH; Sakr W; Djuric Z; Pollak MN; Khachik F; Li YW; Banerjee M; Grignon D; Bertram JS; Crissman JD; Pontes EJ; Wood DP
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):861-8. PubMed ID: 11489752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
